 Secondary outcomes: The investigators will measure cytokine expression and platelet activation as secondary outcomes. Further, the investigators will also collect established measures of clinical outcome such as hospital length of stay, ICU length of stay, duration of postoperative mechanical ventilation, and major adverse cardiac events MACE defined as all-cause mortality, emergent revascularization, atrial fibrillation, stroke, and non-fatal myocardial infarction. 